Protein Expression and Genomic Alterations of PMS2 in Urothelial Bladder Cancer

被引：0
|
作者：
Nozad, Sahar
Shiekhmohammed, Mohammed
Kallakury, Bhaskar V. S.
Sheehan, Christine E.
Elvin, Julia A.
Vergilio, Jo-Anne
Suh, James
Ramkissoon, Shakti H.
Ali, Siraj M.
Schrock, Alexa
Pal, Sumanta
Fisher, Hugh A.
Mian, Badar
Nazeer, Tipu
Fabrizio, David
Frampton, Garrett
Connelly, Caitlin
Miller, Vincent
Stephens, Philip
Gay, Laurie M.
Ross, Jeffrey
机构：
[1] Albany Med Coll, Albany, NY 12208 USA
[2] Georgetown Univ Hosp, Washington, DC 20007 USA
[3] Fdn Med, Cambridge, MA USA
来源：
MODERN PATHOLOGY | 2017年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
994
引用
收藏
页码：246A / 246A
页数：1
相关论文
共 50 条
  • [21] HER2 protein expression in urothelial carcinoma of the bladder
    Nikolaidou, A.
    Balis, G. C.
    Moustakas, G.
    Michalopoulou, E.
    Themeli, I.
    Demertzidis, G.
    Dimasis, N.
    VIRCHOWS ARCHIV, 2012, 461 : S295 - S295
  • [22] DNA mismatch repair protein, PMS2, induces apoptosis in human prostate cancer cells
    Fukuhara, Shinichiro
    Chang, Inik
    Shahryari, Varahram
    Gill, Ankurpreet
    Wong, Darryn K.
    Yamamura, Soichiro
    Majid, Shahana
    Saini, Sharanjot
    Hirata, Hiroshi
    Ueno, Koji
    Deng, Gouren
    Tabatabai, Laura Z.
    Nonomura, Norio
    Dahiya, Rajvir
    Tanaka, Yuichiro
    CANCER RESEARCH, 2014, 74 (19)
  • [23] Somatic genomic alterations in urothelial cancer: Results of the Cancer Genome Atlas (TCGA) bladder cancer (BC) analysis.
    Rosenberg, Jonathan E.
    Kim, Jaegil
    Cherniack, Andrew
    Sougnez, Carrie
    Meyerson, Matthew
    Getz, Gad
    Weinstein, John N.
    Lerner, Seth P.
    Kwiatkowski, David J.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [24] PMS2 expression decrease causes severe problems in mismatch repair
    Kasela, Mariann
    Nystrom, Minna
    Kansikas, Minttu
    HUMAN MUTATION, 2019, 40 (07) : 904 - 907
  • [25] Reduced PMS2 expression decreases significantly mismatch repair efficiency
    Kasela, M.
    Nystrom, M.
    Kansikas, M.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 1579 - 1580
  • [26] Genomic alterations in upper tract urothelial carcinoma (UTUC) versus urothelial carcinoma of the bladder (UBC)
    Mullane, Stephanie A.
    de Velasco, Guillermo
    Choueiri, Toni K.
    Kantoff, Philip W.
    Bellmunt, Joaquim
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [27] Landscape of fibroblast growth factor receptor (FGFR) genomic alterations (GA) in urothelial bladder cancer (UBC).
    Zerdan, Maroun Bou
    Bratslavsky, Gennady
    Jacob, Joseph M.
    Huang, Richard S. P.
    Kravtsov, Oleksandr
    Parimi, Vamsi
    Lin, Douglas I.
    Graf, Ryon
    Danziger, Natalie
    Ross, Jeffrey S.
    Goldberg, Hanan
    Basnet, Alina
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [28] Genomic Characterization of Response to Chemoradiation in Urothelial Bladder Cancer
    Desai, Neil B.
    Scott, Sasinya N.
    Zabor, Emily C.
    Cha, Eugene K.
    Hreiki, Joseph
    Sfakianos, John P.
    Ramirez, Ricardo
    Bagrodia, Aditya
    Rosenberg, Jonathan E.
    Bajorin, Dean F.
    Berger, Michael F.
    Bochner, Bernard H.
    Zelefsky, Michael J.
    Kollmeier, Marisa A.
    Ostrovnaya, Irina
    Al-Ahmadie, Hikmat A.
    Solit, David B.
    Iyer, Gopa
    CANCER, 2016, 122 (23) : 3715 - 3723
  • [29] PMS2 Amplification Contributes Brain Metastasis from Lung Cancer
    Chen, J.
    Su, C.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S306 - S307
  • [30] Late presentation of cancer in compound heterozygote PMS2 mutation carrier
    Paulien P van Galen
    Renee Perrier
    Francois P Bernier
    Hereditary Cancer in Clinical Practice, 9 (Suppl 1)
12345